CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ)
$5.1 0.0045 (0.0883%)
Analysed CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) News Sources
CSBR Stock Dips Post Q4 Earnings Despite Record Revenue Growth, AI Push
30-07-2026
yahoo.com
Champions Oncology Reports Revenue of $15.2 Million
10-09-2026
yahoo.com
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
30-03-2026
yahoo.com
Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026
09-04-2026
yahoo.com
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026
20-07-2026
yahoo.com
Champions Oncology Reports Record Annual Revenue of $59 Million
27-07-2026
yahoo.com
Champions Oncology Inc (CSBR) (Q4 2026) Earnings Call Highlights: Record Revenue and Positive ...
30-07-2026
yahoo.com
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2026
04-09-2026
yahoo.com
Champions Oncology Q1 Earnings Call Highlights
10-09-2026
marketbeat.com
Champions Oncology (CSBR) Q1 2027 Earnings Call Transcript
11-09-2026
fool.com
What is the current price of CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ)?
The current price of CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) is $5.1.
CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) absolute price change since previous trading day?
The absolute price change of CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) since the previous trading day is $0.0045.
CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) percentage price change since previous trading day?
The percentage price change of CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) since the previous trading day is 0.0883%.
What is the most recent average sentiment score for CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ)?
The most recent average sentiment score for CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ)?
The most recent sentiment for CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ) is .
SEC-8K** Filing Available For CHAMPIONS ONCOLOGY INC (CSBR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.